Le Lézard
Classified in: Health, Science and technology
Subject: HEALTH

Brain Canada and Brain Changes Initiative (BCI) launch Innovation Grants for Research Impact in Traumatic Brain Injury


MONTREAL, Aug. 16, 2023 (GLOBE NEWSWIRE) -- It is estimated that approximately 165,000 people per year are affected by a traumatic brain injury (TBI) in Canada. With the knowledge that stakeholder-informed research has the greatest potential for impact, Brain Canada undertook an extensive consultation process to understand the breadth of the needs of diverse stakeholders related to TBI and identify the top priorities that should be addressed first.

Brain Canada, in collaboration with Brain Changes Initiative (BCI) has now launched the Innovation Grants for Research Impact in Traumatic Brain Injury funding opportunity to generate creative, novel and practical evidence-based solutions that address stakeholder-identified and prioritized needs, listed below, to improve the trajectory of recovery for individuals after brain injury.

An overall funding envelope of $1.4M will be available for this program to support three to four grants over two years.?This funding opportunity is open to interdisciplinary research teams of two or more members and must include a minimum of two independent investigators.

Evidence clearly shows that increasing equity, diversity, and inclusion (EDI) in research environments enhances excellence, innovation, and creativity. Brain Canada and Brain Changes Initiative are committed to excellence through equity, and we encourage applicants of diverse backgrounds to apply to our funding opportunities, which will promote the expression of diverse perspectives, approaches, and experiences, including those of underrepresented groups.

Click here to view the Request for Applications.

The registration form deadline is September 27, 2023 at 5 p.m. EST, and the deadline for receipt of full applications is January 25, 2024 at 5 p.m. EST.

This program has been made possible by the Canada Brain Research Fund (CBRF), an innovative arrangement between the Government of Canada (through Health Canada) Brain Canada Foundation, and Brain Changes Initiative (BCI).

About Brain Canada

Brain Canada plays a unique and invaluable role as a national convenor of those who support and advance brain research. A greater understanding of how the brain works contributes to the prevention, diagnosis, treatment, and cure of disorders of the brain, ultimately improving the health outcomes of people in Canada and around the world. Visit Braincanada.ca @BrainCanada

About Brain Changes Initiative (BCI)

Brain Changes Initiative (BCI) is a not-for-profit organization that funds ground-breaking research to improve the standard of care for Traumatic Brain Injury (TBI) recovery. BCI also provides awareness, advocacy and support for Traumatic Brain Injury survivors; they carry out knowledge translation, education, events and programs centred around nonpharmacological approaches to healing the brain. https://www.brainchanges.org/

Media Contact:

Brielle Goulart

Digital Communications and Stewardship Officer

450-915-2253

[email protected]



These press releases may also interest you

at 03:29
Ericsson's annual general meeting on April 3, 2024 authorized the company to, in conjunction with the delivery of vested shares under the long-term variable compensation program 2021 ("LTV 2021"), prior to the annual general meeting in 2025, retain...

at 03:21
W3 Energy and Schierloh Engineering Group are pleased to announce a collaborative partnership to enhance the technical operation of wind farms across Germany. This strategic alliance will enable Schierloh Engineering GmbH to ensure uninterrupted...

at 03:05
In Q1 2024, LEO Pharma delivered a revenue growth of 13% in constant exchange rates (CER). The dermatology portfolio saw accelerated growth in revenue of 16%. The acquisition of TMB-001 to the treatment of congenital ichthyosis added a late-stage...

at 02:38
Sivers Semiconductors AB (STO: SIVE), a leading supplier of integrated chips and modules for advanced communications and sensor solutions for AI Photonics, SATCOM and 5G/6G today reported its first-quarter results for the fiscal year 2024. The...

at 02:22
Hansa Biopharma AB (publ), ("Hansa" or the "Company") (STO: HNSA) today announced that the company's registered share capital and number of shares and votes have increased through the issue of 10,474,740 new ordinary shares on 12 April 2024, whereby...

at 02:20
Vicore Pharma Holding (STO:VICO) Stockholm, May 3 2024- Vicore Pharma Holding AB (STO:VICO) ("Vicore"), unlocking the potential of a new class of drug candidates, angiotensin II type 2 receptor agonists (ATRAGs), publishes the interim...



News published on and distributed by: